Mr. Speaker, while Health Canada does not regulate the price of pharmaceutical products, including isotopes, we continue to work with the provinces and territories on addressing the shortage.
As a matter of fact, we are taking action now. We are ensuring that the testing is available for Canadians by quickly approving alternatives. To date we have approved two clinical trials and ten special access program requests. The clinical trials were approved in a record three days, and we are approving special access program requests in just 24 hours.
We are helping the provinces and territories triage and manage their supply through an expert guidance document.
We are taking action, and I would appreciate the member--